Short interest in Pasithea Therapeutics Corp (NASDAQ:KTTA) increased during the last reporting period, rising from 18.79K to 25.77K. This put 2.46% of the company's publicly available shares short.

Short interest for Pasithea Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Pasithea Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 44.06K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.